Why Cross-Layer Associations Need a Technical Check
Suppose expression and protein abundance are measured in the same set of samples, and the two measurements are strongly associated. The association may reflect shared biology, but it may also arise because both assays were processed in the same laboratory batch, because the samples differ in cell composition, or because a processing feature affects both measurements. The observed correlation alone cannot distinguish these explanations.
This tutorial focuses on diagnosing those sources of cross-layer association and on using design-aware adjustment and negative-control comparisons to assess robustness. A covariate is not automatically a nuisance to remove: its role depends on the scientific question. In particular, cell composition can be a biological feature of interest, a source of confounding, or part of a pathway through which a biological exposure operates.
A Model for Cross-Layer Adjustment
Let \(X_i\) denote a molecular measurement in one omics layer and \(Y_i\) a measurement in another layer for sample \(i\). A basic linear model for their conditional association is
Here, \(\mathbf{C}_i\) contains measured covariates such as batch indicators, estimated cell proportions, and sample-processing variables. The coefficient \(\beta_X\) describes the mean difference in \(Y\) associated with a one-unit difference in \(X\), conditional on the included covariates, under the specified linear model. It is an adjusted association, not automatically a causal effect.
For the usual least-squares interpretation, the model assumes a correctly specified conditional mean, independent samples (or an analysis that accounts for dependence), and errors with conditional mean zero given the predictors and covariates. Standard errors and tests require additional variance assumptions or a suitable robust procedure. A categorical batch variable should generally be represented by indicator columns with a reference level, rather than treated as a numeric scale whose values imply a linear trend.
The adjustment is informative only when the data contain enough overlap to distinguish the predictor from the covariates. If every sample with one value of \(X\) is in one batch and every sample with another value is in another batch, the data may not identify separate effects of \(X\) and batch. No regression option can recover information absent from the design.
Worked Example: A Strong Pooled Correlation That Disappears Within Batch
Hypothetical data. Six samples are processed in two assay batches. \(X\) is a normalized expression measurement, and \(Y\) is a protein measurement in arbitrary units. The values are:
| Batch | \(X\) | \(Y\) |
|---|---|---|
| A | 9 | 99 |
| A | 10 | 98 |
| A | 11 | 99 |
| B | 19 | 109 |
| B | 20 | 108 |
| B | 21 | 109 |
Across all six samples, \(\bar{x}=15\) and \(\bar{y}=103.67\). The sums of squared deviations are \(\sum_i(X_i-\bar{x})^2=154\) and \(\sum_i(Y_i-\bar{y})^2=151.33\). The sum of cross-products is \(150\), so the pooled sample correlation is
The pooled association is very strong, but both measurements shift upward in batch B. To see what happens after controlling for batch, subtract each batch mean from each measurement. In each batch, the centered \(X\) values are \((-1,0,1)\) and the centered \(Y\) values are \((1/3,-2/3,1/3)\). Their cross-product sum in each batch is
The within-batch cross-product is therefore zero in both batches and in their combination. In this data set, the pooled correlation is driven by the common batch shift; after removing batch means, there is no linear within-batch association. This does not establish that batch caused the shifts, but it shows why the pooled correlation alone is inadequate evidence for a cross-layer biological relationship.
Confounding and Identifiability
A simple derivation shows how an omitted batch factor can distort a cross-layer slope. Suppose the true model is \(Y_i=\beta_X X_i+\gamma B_i+\varepsilon_i\), where \(B_i\) is a numeric indicator for a batch contrast. Assume \(E(\varepsilon_i\mid X_i,B_i)=0\). If \(Y\) is instead regressed on \(X\) alone, the population slope is
To obtain this expression, substitute the true model into the covariance: \(\operatorname{Cov}(X,Y)=\beta_X\operatorname{Var}(X)+\gamma\operatorname{Cov}(X,B)+\operatorname{Cov}(X,\varepsilon)\). The final term is zero under the stated conditional-mean assumption. Dividing by \(\operatorname{Var}(X)\) gives the result. Thus, when batch affects \(Y\) and is associated with \(X\), the unadjusted slope generally combines the cross-layer association and a batch-related component.
Adjustment does not always solve the problem. If \(X\) and batch are perfectly aligned, their separate coefficients cannot be estimated. For example, if the batch indicator vector equals the predictor vector for every sample, the two corresponding columns of the design matrix are identical. Adding both to a regression does not create two independent sources of information; only a combined contribution is estimable. With partial overlap, adjustment may be possible but imprecise, and conclusions can depend heavily on a small number of samples in the overlapping groups.
Covariate columns can also be nonorthogonal without being identical. The following cross-product calculation illustrates why checking arithmetic and the design itself matters.
Worked Example: Checking Dependence Between Two Design Columns
Hypothetical design diagnostic. Consider two columns in a design matrix, \(u=(-1,-1,-1,1)^{\mathsf T}\) and \(v=(-1,3,-3,1)^{\mathsf T}\), representing two coded sample features. Their inner product is
The squared lengths are \(u^{\mathsf T}u=4\) and \(v^{\mathsf T}v=20\). Their cosine similarity is therefore
The columns are not orthogonal, but neither are they proportional: their nonzero cross-product does not imply perfect confounding. This calculation is a design-matrix diagnostic, not a substitute for a model that includes the intercept and the chosen coding of categorical variables. The practical question is whether the relevant biological predictor has adequate variation within the technical groups, and whether the model matrix has enough independent information to estimate the desired coefficients.
Choose Adjustments With the Design and Scientific Question in View
A robust analysis begins before fitting a model. If samples from distinct biological groups were processed in separate batches, batch and biology may be inseparable. Whenever possible, randomize samples across plates and runs, balance important biological groups within each batch, and record processing variables at collection and assay. These choices create overlap that makes adjustment more credible.
When adjusting, include covariates that plausibly affect the measured outcomes and are related to the predictor or outcome of interest. For batch, use an appropriate categorical representation. For cell composition, use suitable measured or estimated proportions and consider whether the target is a within-cell-type association or an association that includes changes in cell mixture. If composition lies on a biological pathway relevant to the question, adjusting for it changes the estimand and may remove part of the relationship being studied. Processing variables can likewise be consequences of sample quality or biological state; automatic adjustment can introduce bias if a variable is affected by both the exposure and unmeasured causes of the outcome.
Inspect group counts and cross-tabulations, examine whether covariate values overlap across biological groups, and assess the rank and conditioning of the design matrix. A fitted coefficient can be returned by software even when it is unstable or its interpretation depends on near-confounding. Report which covariates were adjusted for and why, and distinguish the adjusted association from the unadjusted one.
Worked Example: Using a Negative Control to Probe Robustness
Hypothetical analysis. An analyst fits the same cross-layer regression in the same samples with the same batch and cell-composition covariates. The target expression-protein coefficient is \(0.80\) protein units per expression unit before technical adjustment and \(0.20\) after adjustment. A negative-control molecular outcome, selected because the proposed biological mechanism is not expected to affect it, has a coefficient of \(0.55\) before adjustment and \(0.05\) after adjustment.
The target coefficient changes by
protein units per expression unit, a reduction of \(0.60/0.80=0.75\), or 75% of its original magnitude. The negative-control coefficient changes by \(0.05-0.55=-0.50\) units per expression unit. Its large unadjusted association and attenuation after adjustment are consistent with shared technical structure affecting more than the target pair.
This comparison is a diagnostic, not a proof that the adjusted target association is biological. A useful negative control must share relevant technical vulnerabilities while lacking the biological relationship under the stated hypothesis. If that assumption is wrong, the comparison is hard to interpret. The adjusted target coefficient remains an association conditional on the included covariates; uncertainty intervals, model diagnostics, and the design must also be considered before drawing conclusions.
What Robustness Checks Can and Cannot Establish
Cross-layer results are more persuasive when they are not driven by one obvious technical contrast. Useful checks include comparing estimates before and after adjustment, examining within-batch associations when there is adequate within-batch variation, and repeating the analysis under reasonable alternative representations of batch or composition. The purpose is not to search for a preferred coefficient, but to determine whether the conclusion changes materially under plausible specifications.
Negative-control outcomes or exposures can help identify residual structure. A negative-control outcome should be affected by relevant technical processes but not by the hypothesized biological link. A negative-control exposure should share important confounding structure but not have the proposed causal connection. Neither is a generic substitute for design or a universal test of confounding; the scientific assumptions that make a control negative must be stated.
Common Mistakes
- Wrong: “The adjusted coefficient is biological because batch was included.” Correction: Adjustment controls only modeled covariates under the model assumptions; it does not rule out unmeasured or misspecified technical effects.
- Wrong: “A large batch effect means the molecular layers are unrelated.” Correction: Batch may explain some observed association, while a biological association may still remain. Estimate and interpret both with uncertainty and design limitations in view.
- Wrong: “Adding batch to the model separates batch and biology even when they never overlap.” Correction: Perfect confounding prevents separate estimation; additional samples with overlap or a redesigned experiment are needed.
- Wrong: “Cell composition is always a nuisance covariate.” Correction: Its role depends on the target question. Adjustment may be appropriate for a within-composition association but may remove part of a biologically meaningful pathway.
- Wrong: “A null negative-control result proves there is no residual technical confounding.” Correction: A control can be insensitive to some artifacts, and its interpretation depends on whether it truly shares the relevant technical structure.
Check Your Understanding
Use the model, design, and diagnostic ideas in this tutorial to answer the following questions.
- Both expression and protein measurements shift between assay batches. What comparison would help determine whether their pooled association is also present within batches?
- Explain why a regression cannot separately estimate a molecular predictor effect and a batch effect when the corresponding design columns are identical.
- In the omitted-variable derivation, what two features make the unadjusted slope differ from the conditional slope?
- Why does a nonzero cross-product between two design columns not, by itself, establish perfect confounding?
- What assumptions make a molecular outcome a useful negative control for a proposed cross-layer relationship?
- Give one reason why adjusting for cell composition can change the scientific estimand rather than simply remove bias.